CN102327451B - Chinese medicinal composition for treating chronic sinusitis - Google Patents
Chinese medicinal composition for treating chronic sinusitis Download PDFInfo
- Publication number
- CN102327451B CN102327451B CN 201110309935 CN201110309935A CN102327451B CN 102327451 B CN102327451 B CN 102327451B CN 201110309935 CN201110309935 CN 201110309935 CN 201110309935 A CN201110309935 A CN 201110309935A CN 102327451 B CN102327451 B CN 102327451B
- Authority
- CN
- China
- Prior art keywords
- parts
- medicaments
- radix
- medicinal composition
- chinese medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of traditional Chinese medicines and discloses a Chinese medicinal composition for treating chronic sinusitis. The Chinese medicinal composition is prepared from the following raw material medicaments in part by weight: 25 to 35 parts of honeysuckle flower, 15 to 25 parts of biond magnolia flower, 10 to 20 parts of siberian cocklour fruit, 10 to 20 parts of angelica dahurica, 7 to 17 parts of baical skullcap root, 10 to 20 parts of Chinese thorowax root, 10 to 20 parts of gentian, 7 to 17 parts of rhizoma anemarrhenae, 15 to 25 parts of astragalus, 5 to 15 parts of manchurian wildginger and 5 to 15 parts of liquoric root. The Chinese medicinal composition has the advantages that: chief medicaments, deputy medicaments, adjuvant medicaments and envoy medicaments have appropriate compatibility; the selected medicaments are excellent and combined; the Chinese medicinal composition has the effects of clearing heat and drying damp, diffusing and freeing the orifices, tonifying vitality and strengthening exterior, and strengthening body resistance and eliminating evil, can quickly remove sinus inflammation, restrain mucosal secretion and quickly eliminate clinical symptoms, has the effects of reconstructing damaged nasal mucosa and recovering the cleaning function of nasal mucosa cilia, consolidates the curative effect, does not have adverse effects after being taken for a long time, is safe to take, has an exact curative effect and is worth of clinical popularization.
Description
Technical field
The invention belongs to technical field of Chinese medicines, be specifically related to a kind of Chinese medicine composition for the treatment of chronic sinusitis.
Background technology
Chronic sinusitis is common clinical, frequently-occurring disease, due to majority is untimely or thorough because of the acute sinusitis treatment.Because day by day serious environmental pollution, the whole world be people's morbidity of 15% approximately.Preschool rear school age, the section child-the teenager sickness rate was higher, and year by year ascendant trend is arranged.Its main manifestations is for the glutinous pus tears of stream, nasal obstruction, with dizzy, feeling of fullness in the head even hypomnesis.Traditional nasal sinus opening radical correction and the Endoscopic Sinus Surgery of in recent years promoting be can yet be regarded as and treated the effective ways of chronic sinusitis.Yet, in view of child-teenager nasal sinuses structural development not yet complete, the sinunasal physiological function obstacle reversibility that inflammation causes is large, and child-teenager is difficult to tolerate invasive surgery, and most doctors are devoted to seek child-adolescent chronic sinusitis expectant treatment method.
Summary of the invention
The object of the present invention is to provide a kind of Chinese medicine composition for the treatment of chronic sinusitis.
For achieving the above object, the technical scheme taked of the present invention is as follows:
A kind of Chinese medicine composition for the treatment of chronic sinusitis is made by each crude drug of following portions by weight: 25 ~ 35 parts of Flos Loniceraes, 15 ~ 25 parts of Flos Magnoliaes, 10 ~ 20 parts of Fructus Xanthii, 10 ~ 20 parts of the Radixs Angelicae Dahuricae, 7 ~ 17 parts of Radix Scutellariaes, 10 ~ 20 parts of Radix Bupleuri, 10 ~ 20 parts of Radix Gentianaes, 7 ~ 17 parts of the Rhizoma Anemarrhenaes, 15 ~ 25 parts of the Radixs Astragali, 5 ~ 15 parts of Herba Asaris, 5 ~ 15 parts in Radix Glycyrrhizae.
Optimum formula of the present invention is (weight portion): 30 parts of Flos Loniceraes, 20 parts of Flos Magnoliaes, 15 parts of Fructus Xanthii, 15 parts of the Radixs Angelicae Dahuricae, 12 parts of Radix Scutellariaes, 15 parts of Radix Bupleuri, 15 parts of Radix Gentianaes, 12 parts of the Rhizoma Anemarrhenaes, 20 parts of the Radixs Astragali, 10 parts of Herba Asaris, 10 parts in Radix Glycyrrhizae.
Traditional Chinese medical science traditional theory thinks that chronic sinusitis belongs to " nasal sinusitis " category.It is because deficiency of the spleen and lung, instability of surface, and evil poison is damp and hot to gather that nasal sinuses, nose key are corrupt to suppurate and cause.The present invention is principal agent with Flos Lonicerae, Fructus Xanthii, Flos Magnoliae, and lung qi dispersing is sensible, the heat clearing and damp drying spleen invigorating.Radix Scutellariae, the Radix Astragali, Herba Asari, the Rhizoma Anemarrhenae are ministerial drug, wherein, and the Radix Astragali, benefiting QI for strengthening the superficies, strengthening vital QI to eliminate pathogenic factors; Radix Scutellariae, the removing summer-heat lung-heat; Herba Asari, analgesic, antiinflammatory, analgesia; The Rhizoma Anemarrhenae, clearing away heat-fire, nourshing Yin and drynsessmoistening prescription.Radix Bupleuri, Radix Gentianae, the Radix Angelicae Dahuricae are adjuvant drug, wherein, and Radix Bupleuri, dispelling wind and heat pathogens; Radix Gentianae, the fire of heat clearing and damp drying, eliminating pathogen in the liver gallbladder; The Radix Angelicae Dahuricae, cold expelling is sensible, wind-expelling pain-stopping, detumescence and apocenosis, the priming sick institute that goes directly.Radix Glycyrrhizae is for making medicine, clearing away heat-fire, coordinating the actions of various ingredients in a prescription.Medicine monarch compatibility of the present invention is appropriate, select YAOJING good, all medicines share, have that heat clearing and damp drying, a surname are loose sensiblely not only can eliminate the nasal sinuses inflammation fast with, benefiting QI for strengthening the superficies, the double effect of executing of strengthening vital QI to eliminate pathogenic factors, suppress mucosa and secrete, eliminate rapidly clinical symptoms, and have the effect of repairing destroyed nasal mucosa, recovering nasal mucosa cilium cleaning function, therefore curative effect is good, clinic is promoted.
Preparation method: make according to a conventional method any clinically acceptable preparation, can according to the needs of different preparations, choose and add corresponding conventional adjuvant.The preferred watered pill of preparation or granule, the more preferably watered pill.
The advantage of medicine of the present invention: the monarch compatibility is appropriate, select YAOJING good, all medicines share, have heat clearing and damp drying, a surname loose sensible with, benefiting QI for strengthening the superficies, the double effect of executing of strengthening vital QI to eliminate pathogenic factors, not only can eliminate fast the nasal sinuses inflammation, suppress the mucosa secretion, eliminate rapidly clinical symptoms, and have the effect of repairing destroyed nasal mucosa, recovering nasal mucosa cilium cleaning function, therefore curative effect is good; Long-term taking has no adverse reaction, and uses safety, determined curative effect, and clinic is promoted.
The specific embodiment
Embodiment 1
By following weight, take by weighing each crude drug: Flos Lonicerae 30g, Flos Magnoliae 20g, Fructus Xanthii 15g, Radix Angelicae Dahuricae 15g, Radix Scutellariae 12g, Radix Bupleuri 15g, Radix Gentianae 15g, Rhizoma Anemarrhenae 12g, Radix Astragali 20g, Herba Asari 10g, Radix Glycyrrhizae 10g.After above each crude drug cleaned up, dries, pulverize and be fine flour, cross 200 mesh sieves, the general watered pill (being commonly called as the Flos Lonicerae ball), the every ball 0.1g of making.
Embodiment 2
By following weight, take by weighing each crude drug: Flos Lonicerae 25g, Flos Magnoliae 15g, Fructus Xanthii 10g, Radix Angelicae Dahuricae 10g, Radix Scutellariae 7g, Radix Bupleuri 10g, Radix Gentianae 10g, Rhizoma Anemarrhenae 7g, Radix Astragali 15g, Herba Asari 5g, Radix Glycyrrhizae 5g.After above each crude drug cleaned up, dries, pulverize and be fine flour, cross 200 mesh sieves, the general watered pill (being commonly called as the Flos Lonicerae ball), the every ball 0.1g of making.
Embodiment 3
By following weight, take by weighing each crude drug: Flos Lonicerae 35g, Flos Magnoliae 25g, Fructus Xanthii 20g, Radix Angelicae Dahuricae 20g, Radix Scutellariae 17g, Radix Bupleuri 20g, Radix Gentianae 20g, Rhizoma Anemarrhenae 17g, Radix Astragali 25g, Herba Asari 15g, Radix Glycyrrhizae 15g.After above each crude drug cleaned up, dries, pulverize and be fine flour, cross 200 mesh sieves, the general watered pill (being commonly called as the Flos Lonicerae ball), the every ball 0.1g of making.
The observation on Clinical Application report
One, basic document (in January, 2002 ~ 2011 year JIUYUE)
Accept altogether patient's 2000 examples for medical treatment, male's 1203 examples wherein, women's 797 examples, the age is 3--60 year, the shortest person of the course of disease two months, elder more than 30 years.
Two, diagnostic criteria
(1), symptom
1, cardinal symptom: nasal obstruction, stickiness, purulence nasal mucus.
2, minor symptom: Head And Face distending pain, hyposmia or forfeiture.
During diagnosis take above-mentioned two or more relevant symptoms as foundation, the nasal obstruction in the cardinal symptom wherein, stickiness, the purulence nasal mucus must the tool one.
(2), check
1, nasal cavity inspection: derive from the glutinous purulent secretion of middle nasal meatus, olfactory cleft, middle nasal meatus's mucosa is congested, edema or nasal polyp is arranged.
2, imaging examination: CT scan shows hole mouth sinotunnel c omplex or nasal meatus mucosa pathological changes.
Three, criterion of therapeutical effect
Cure: clinical symptom disappearance, nasal cavity inspection and CT scan all show without pathological changes.
Produce effects: clinical symptoms is significantly improved, and the equal lesions showed of nasal cavity inspection and CT scan is significantly improved.
Invalid: clinical symptoms is without obvious improvement, and the equal lesions showed of nasal cavity inspection and CT scan is without obvious improvement.
Four, Therapeutic Method
The embodiment of the invention 1 Flos Lonicerae ball, each 9 gram (90)/children below 12 years old 6 grams (60) of being grown up, every day 2 times is oral, continues to take 2 weeks.
Five, therapeutic effect
Cure 969 examples, produce effects 931 examples, invalid 100 examples, total effective rate is 95%.
Model case
Case 1
The Wang, the man, 11 years old, the village, temple, Si Zhuan township village school was learned the student, JIUYUE was gone to a doctor on the 25th in 2006, told frons headache, feeling of fullness in the head, the dense thick tears of stream 2 years, through treatment effect is not good in many ways, the nasal sinuses CT examination shows: bilateral frontal sinusitis suppurate (fluid level is arranged), give the embodiment of the invention 1 Flos Lonicerae ball 6 grams, every day 2 times is oral, and 7 days afterwards headaches, feeling of fullness in the heads disappear, dense thick tears reduce the recovery from illness of 2 weeks.
Case 2
Ma, man, 13 years old, the northern junior middle school student of institute in the Nanyue County one, on August 16th, 2007 is medical, tells frons, the headache of bilateral temple place, dizzy 5 months, the distractibility of listening to the teacher, hypomnesis, school grade descends, and the nasal sinuses CT examination shows: bilateral sinus frontalis, maxillary sinusitis (fluid level is arranged) give the embodiment of the invention 2 Flos Lonicerae balls 9 grams, every day 2 times is oral, transference cures after 2 weeks.
Case 3
Korea Spro, woman, 56 years old, Korea Spro Zhang Zhennan street, Nanyue County village peasant, on July 20th, 2007 is medical, tells headache, dizziness 30 years, take " tablet for alleviating pain " pain relieving every day, oneself suspect that brain is ill, require to do cranium brain MRI and check, check result shows: cranium brain no abnormality seen, bilateral frontal sinusitis (mucosa) gives the embodiment of the invention 3 Flos Lonicerae balls 9 gram, and every day 2 times, oral and period in a medicine was withdrawn " tablet for alleviating pain ", not recurrence in 1 year is followed up a case by regular visits in recovery from illness after 2 weeks.
Claims (4)
1. a Chinese medicine composition for the treatment of chronic sinusitis is characterized in that being made by each crude drug of following portions by weight: 25 ~ 35 parts of Flos Loniceraes, 15 ~ 25 parts of Flos Magnoliaes, 10 ~ 20 parts of Fructus Xanthii, 10 ~ 20 parts of the Radixs Angelicae Dahuricae, 7 ~ 17 parts of Radix Scutellariaes, 10 ~ 20 parts of Radix Bupleuri, 10 ~ 20 parts of Radix Gentianaes, 7 ~ 17 parts of the Rhizoma Anemarrhenaes, 15 ~ 25 parts of the Radixs Astragali, 5 ~ 15 parts of Herba Asaris, 5 ~ 15 parts in Radix Glycyrrhizae.
2. the Chinese medicine composition for the treatment of chronic sinusitis as claimed in claim 1 is characterized in that being made by each crude drug of following portions by weight: 30 parts of Flos Loniceraes, 20 parts of Flos Magnoliaes, 15 parts of Fructus Xanthii, 15 parts of the Radixs Angelicae Dahuricae, 12 parts of Radix Scutellariaes, 15 parts of Radix Bupleuri, 15 parts of Radix Gentianaes, 12 parts of the Rhizoma Anemarrhenaes, 20 parts of the Radixs Astragali, 10 parts of Herba Asaris, 10 parts in Radix Glycyrrhizae.
3. the Chinese medicine composition for the treatment of chronic sinusitis as claimed in claim 1 or 2 is characterized in that: make according to a conventional method any clinically acceptable preparation.
4. the Chinese medicine composition for the treatment of chronic sinusitis as claimed in claim 3, it is characterized in that: described preparation is the watered pill or granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110309935 CN102327451B (en) | 2011-10-13 | 2011-10-13 | Chinese medicinal composition for treating chronic sinusitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110309935 CN102327451B (en) | 2011-10-13 | 2011-10-13 | Chinese medicinal composition for treating chronic sinusitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102327451A CN102327451A (en) | 2012-01-25 |
| CN102327451B true CN102327451B (en) | 2013-04-03 |
Family
ID=45479582
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110309935 Expired - Fee Related CN102327451B (en) | 2011-10-13 | 2011-10-13 | Chinese medicinal composition for treating chronic sinusitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102327451B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104127570A (en) * | 2014-06-18 | 2014-11-05 | 陈筠 | Traditional Chinese medicine composition for treating chronic rhinitis |
| CN109512960A (en) * | 2019-01-09 | 2019-03-26 | 郝杰兵 | A kind of pharmaceutical formulation for treating rhinitis and nasosinusitis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101491615A (en) * | 2009-02-25 | 2009-07-29 | 韩伯杨 | Medicine for treating rhinitis and its preparation method |
-
2011
- 2011-10-13 CN CN 201110309935 patent/CN102327451B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN102327451A (en) | 2012-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102512552B (en) | Traditional Chinese medicine composition for treating exogenous fever | |
| CN102327451B (en) | Chinese medicinal composition for treating chronic sinusitis | |
| CN104524247B (en) | One treats migrainous medical composition and its use | |
| CN104147194B (en) | Traditional Chinese medicine composition for treating chronic sinusitis | |
| CN102657706A (en) | Infantile anti-cold umbilical therapeutic ointment | |
| CN101579185B (en) | Pharmaceutical rhinitis pillow for external use and treating wind-cold rhinitis | |
| CN103405602A (en) | Medicament for treating asthma | |
| CN104013836A (en) | Traditional Chinese medicine composition for treating sequela of cerebral apoplexy | |
| CN104258113B (en) | A kind of Chinese medicine composition for the treatment of cerebral hemorrhage | |
| CN102166319B (en) | Soup for treating wind cold | |
| CN102284035A (en) | Chinese composition for treating rhinitis | |
| CN102784252B (en) | Traditional Chinese medicine composition for treating nasosinusitis | |
| CN110841007B (en) | Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof | |
| CN107095977A (en) | A kind of medicament and its pharmaceutical formulation and preparation method with the malicious effect of fire row of dispelling | |
| CN101502597A (en) | Medicament for treating stomachache and preparation method thereof | |
| CN104474173A (en) | Medicine for treating facial nerve paralysis | |
| CN104758346A (en) | Medicine for treating migraine, as well as preparation method and preparation of medicine | |
| CN105106814A (en) | Traditional Chinese medicine combination for treating viral rhinitis | |
| CN104825646A (en) | Traditional Chinese medicinal composition for treating myopia | |
| CN104435133A (en) | Medicament for reducing fever | |
| CN114601876A (en) | Traditional Chinese medicine composition and application thereof in preparation of medicine for treating chronic rhinitis | |
| CN104225281A (en) | Traditional Chinese medicine for treating nasosinusitis | |
| CN104027571A (en) | Traditional Chinese medicine composition for treating chronic pulmonary heart disease | |
| CN102114183A (en) | Medicament for treating hypertension | |
| CN103948783A (en) | Pharmaceutical composition for preventing and/or treating cerebral infarction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130403 Termination date: 20141013 |
|
| EXPY | Termination of patent right or utility model |